Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 4-(2-Chloroethyl)morpholine | HCID 76727 | — |
| Reactant | HCID 178488641 | HCID 178488641 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 44464173 | HCID 44464173 | 94% |
Reaction Steps
To a solution of 3-hydroxy-5-methyl-1-(5-methoxynaphthalen-2-yl)-1H-pyrazol (150 mg, 0.59 mmol) in dimethylformamide (10 ml), 2-chloroethylmorpholine chlorhydrate (136 mg, 0.71 mmol), K2CO3 (245 mg, 1.77 mmol), and NaI (catalytic quantity) were added. The mixture was heated, in an inert nitrogen atmosphere, at 90° C. during 8 hrs. Subsequently it was cooled, filtered, and the filtered product was evaporated to dryness in a rotavapor. The residue was divided between water and ethylic ether. The organic phase was washed with water and afterwards with an aqueous solution of HCl 2N several times. The collection of the acidic aqueous phases were basified with a solution of NaOH 20% and it was extracted with ethyl acetate, which was washed with water, dried over sodium sulfate, filtered, and evaporated to dryness yielding 204 mg (94%) of 4-{2-[1-(5-methoxynaphthalen-2-yl)-5-methyl-1H-pyrazol-3-yloxy]ethyl}morpholine in the form of an oil.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08492425B2 |
|---|
| Source dataset | uspto-grants-2013_07 |
|---|
| ORD ID | ord-44ac6d514ba14ab1ba63d4d07f6a9261 |
|---|
| Source note | uspto-grants-2013_07 |
|---|